TOBAM’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-112,901
Closed -$7.89M 455
2022
Q3
$7.89M Buy
112,901
+63,164
+127% +$4.41M 0.55% 56
2022
Q2
$3.34M Buy
+49,737
New +$3.34M 0.21% 84
2021
Q2
Sell
-160
Closed -$27K 450
2021
Q1
$27K Hold
160
﹤0.01% 420
2020
Q4
$35K Buy
+160
New +$35K ﹤0.01% 388